MARKET

ZTS

ZTS

Zoetis
NYSE

Real-time Quotes | Nasdaq Last Sale

164.66
+1.19
+0.73%
Opening 10:35 04/14 EDT
OPEN
164.33
PREV CLOSE
163.47
HIGH
164.84
LOW
163.70
VOLUME
262.18K
TURNOVER
--
52 WEEK HIGH
176.64
52 WEEK LOW
121.50
MARKET CAP
78.22B
P/E (TTM)
48.11
1D
5D
1M
3M
1Y
5Y
Veterinary Drugs Market Size 2021 by Opportunities, Challenges, Risks, Influences Factors Analysis and Forecast to 2025 Research Report by Absolute Reports
Apr 14, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." An animal drug (also veterinary drug)...
The Express Wire · 2h ago
Veterinary Research Laboratory (Vrl) Market Size to Witness Huge Growth by 2028
Apr 14, 2021 (Market Insight Reports) -- Selbyville, Delaware According to the research report titled 'GLOBAL Veterinary Research Laboratory (Vrl) Market...
Market Insight Reports · 8h ago
Bennett Selby Investments Lp Buys Microsoft Corp, Domino's Pizza Inc, Floor & Decor ...
GuruFocus News · 16h ago
Carl P. Sherr & Co., LLC Buys iShares Core MSCI Total International Stock ETF, Zoetis Inc, ...
GuruFocus News · 18h ago
Norway Savings Bank Buys iShares MBS ETF, PIMCO Active Bond ETF, Generac Holdings Inc, Sells ...
GuruFocus News · 22h ago
Should You Be Impressed By Zoetis Inc.'s (NYSE:ZTS) ROE?
Simply Wall St. · 23h ago
FibroGen (FGEN) DMD Drug Pamrevlumab Gets FDA's Fast Track Tag
Zacks.com · 1d ago
Global Veterinary Diagnostics Market (2021 to 2026) - Growth, Trends, COVID-19 Impact, and Forecasts
Dublin, April 13, Apr 13, 2021 (GLOBE NEWSWIRE via COMTEX) -- Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Veterinary Diagnostics Market - Growth, Trends,...
GlobeNewswire · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ZTS. Analyze the recent business situations of Zoetis through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 20 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ZTS stock price target is 186.67 with a high estimate of 210.00 and a low estimate of 159.00.
EPS
Institutional Holdings
Institutions: 1.72K
Institutional Holdings: 459.42M
% Owned: 96.72%
Shares Outstanding: 475.02M
TypeInstitutionsShares
Increased
582
17.03M
New
168
2.28M
Decreased
435
22.18M
Sold Out
67
1.19M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.48%
Pharmaceuticals & Medical Research
+1.07%
Key Executives
Non-Executive Chairman/Independent Director
Michael McCallister
Chief Executive Officer/Director
Kristin Peck
Chief Financial Officer/Executive Vice President
Glenn David
Chief Human Resource Officer/Executive Vice President
Roxanne Lagano
Executive Vice President/General Counsel/Secretary
Heidi Chen
Executive Vice President
Catherine Knupp
Executive Vice President
Roman Trawicki
Director
Juan Alaix
Director
Antoinette Leatherberry
Independent Director
Frank D'Amelio
Independent Director
Paul Bisaro
Independent Director
Frank D'amelio
Independent Director
Sanjay Khosla
Independent Director
Gregory Norden
Independent Director
Louise Parent
Independent Director
Willie Reed
Independent Director
Linda Rhodes
Independent Director
Robert Scully
Independent Director
William Steere
Declaration Date
Dividend Per Share
Ex-Div Date
02/10/2021
Dividend USD 0.25
04/20/2021
12/09/2020
Dividend USD 0.25
01/19/2021
10/07/2020
Dividend USD 0.2
10/20/2020
05/20/2020
Dividend USD 0.2
07/16/2020
02/11/2020
Dividend USD 0.2
04/16/2020
12/11/2019
Dividend USD 0.2
01/16/2020
10/03/2019
Dividend USD 0.164
10/21/2019
05/15/2019
Dividend USD 0.164
07/18/2019
02/12/2019
Dividend USD 0.164
04/17/2019
12/12/2018
Dividend USD 0.164
01/17/2019
10/10/2018
Dividend USD 0.126
11/19/2018
05/15/2018
Dividend USD 0.126
07/19/2018
02/13/2018
Dividend USD 0.126
04/19/2018
12/11/2017
Dividend USD 0.126
01/18/2018
10/05/2017
Dividend USD 0.105
11/08/2017
05/22/2017
Dividend USD 0.105
06/13/2017
02/15/2017
Dividend USD 0.105
04/04/2017
12/07/2016
Dividend USD 0.105
01/18/2017
10/06/2016
Dividend USD 0.095
11/01/2016
05/13/2016
Dividend USD 0.095
06/28/2016
02/22/2016
Dividend USD 0.095
04/05/2016
12/18/2015
Dividend USD 0.095
01/19/2016
10/01/2015
Dividend USD 0.083
11/03/2015
07/21/2015
Dividend USD 0.083
08/11/2015
02/27/2015
Dividend USD 0.083
04/07/2015
12/17/2014
Dividend USD 0.083
01/20/2015
10/02/2014
Dividend USD 0.072
11/03/2014
07/31/2014
Dividend USD 0.072
08/18/2014
03/27/2014
Dividend USD 0.072
04/24/2014
12/19/2013
Dividend USD 0.072
01/28/2014
09/13/2013
Dividend USD 0.065
10/30/2013
06/21/2013
Dividend USD 0.065
07/30/2013
About ZTS
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.

Webull offers kinds of Zoetis Inc stock information, including NYSE:ZTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZTS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZTS stock methods without spending real money on the virtual paper trading platform.